Clinical Trials Browser

Phase 2 × Glioma × Vorinostat × Clear all

NCT01738646 2017-03-06

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Phase 2 Completed

48 enrolled 10 charts

Brain Neoplasms, Glioblastoma, Glioma